Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
1 raison identifiée
Auteur de référence en rhumatologie
24 articles scientifiques publiés — un praticien à la pointe de la recherche
✨ Génération du profil synthétique IA en cours…
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Cancer medicine · 2023
AbstractBackgroundCOVID‐19 affected healthcare worldwide, limited access to healthcare, and delayed cancer screening and diagnosis. In this study, the effect of the first year of COVID‐19 was determined on cancer diagnoses in the province of Quebec, Canada.MethodsData were collected from the 13 Quebec Cancer Registry health institutions. Newly diagnosed cancer declarations in the first year of the COVID‐19 (April 2020–March 2021) were compared with the reference periods (averages of 3 previous years). The main focus was on four leading cancers: lung, prostate, colorectal, and breast cancers. Generalized regression models with a poisson approximation and interrupted time series (ITS) analysis were used. Underestimated cases were presented in terms of relative risk (RR) and 95% confidence intervals (CI). The changes in the stage‐specific counts were also assessed in each of the four cancers. Results were illustrated separately for the first 4 months of the pandemic (first wave).FindingsThis study estimated an overall under‐reporting of 15.3% (29,019 vs. 24,584) of declarations. This under‐reporting was evident across all age groups above 35 years (p < 0.0001), four primary cancers (p < 0.0001), all stages of cancers (p < 0.0001), and both sexes (p < 0.0001). Based on the relative risks, stage‐specific lung cancer counts were underestimated by 5%–34% in the first wave (0%–11% in the first year), prostate cancer by 16%–46% in the first wave (0%–25% in the first year), colorectal cancer 15%–45% in the first wave (0%–24% in the first year), and breast cancer 3%–45% in the first wave and (0%–28% in the first year). However, no stage‐IV cancers were statically under‐reported compared to the pre‐pandemic era and not even in the first wave.InterpretationCancer diagnosis was underestimated due to the COVID‐19 pandemic in the first year; this effect was more evident in the first phase of the pandemic in Quebec. Further research is required to determine the accurate burden of the disease in the long term.
Stem cells translational medicine · 2022
Abstract As in younger patients, allogeneic stem cell transplantation (alloHSCT) offers the best chance for durable remission in older patients (≥60 years) with acute myeloid leukemia (AML). However, defining the best treatment strategy (and in particular, whether or not to proceed to alloHSCT) for elderly patients with AML remains a difficult decision for the hematologist, since potential toxicity of conditioning regimens, risks of graft-versus-host disease, impaired immune reconstitution and the need for prolonged immunosuppression may be of major concern in these vulnerable patients with complex needs. Hopefully, significant progress has been made over the past decade in alloHSCT for elderly patients and current evidence suggests that chronological age per se (between 60 and 75) is not a reliable predictor of outcome after alloHSCT. Here, we review the current state of alloHSCT in elderly patients with AML and also discuss the different approaches currently being investigated to improve both accessibility to as well as success of alloHSCT in these patients.
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Journal of the National Comprehensive Cancer Network : JNCCN · 2026 · Journal Article
Bailey A, Frederic W, Orr A, McCarson S, et al.
PLoS medicine · 2026 · Journal Article
Ayehu T, Joekai JF Jr, Yorgbor MK, Clark ET, et al.
Heliyon · 2024 · Journal Article
Allagbé I, Nicolas R, Airagnes G, Frédéric L, et al.
The Journal of clinical endocrinology and metabolism · 2024 · Letter
Cecilia P, Frederic C
Emergency medicine journal : EMJ · 2023 · Journal Article
Hong Tuan Ha V, Jost D, Bougouin W, Joly G, et al.
Kidney international · 2023 · Journal Article
Gregory AV, Chebib FT, Poudyal B, Holmes HL, et al.
Frontiers in pain research (Lausanne, Switzerland) · 2023 · Journal Article
Van Zyl J, Knotkova H, Kim P, Henderson CR Jr, et al.
Cancer medicine · 2023 · Journal Article
Ramanakumar AV, Annie B, Frederic L, Christine B, et al.
bioRxiv : the preprint server for biology · 2023 · Preprint
Louise R, Manon L, Vincent E, Andréanne L, et al.
Diagnostic microbiology and infectious disease · 2022 · Journal Article
Anne-Gaëlle R, Célia S, Jeanne C, Frédéric B, et al.
Journal of the Pediatric Infectious Diseases Society · 2026 · Journal Article
Lenglart L, Levy C, Cahn-Sellem F, Zouari M, et al.
The Journal of infection · 2024 · Journal Article
Clément L, Hélène D, Maud M, Chrystelle D, et al.
International emergency nursing · 2023 · Journal Article
Christel H, Aubry SC, Florence T, Nora EB, et al.
Journal of the National Medical Association · 2026 · Case Reports
Frederic J, Oladoyin V, Geetha J, Muhammad A, et al.
Clinical case reports · 2023 · Case Reports
Timour G, Fréderic V, Olivier S, Shango DN
BMC oral health · 2022 · Journal Article
Benoit B, Frédéric B, Jean-Charles D
International journal of surgery case reports · 2024 · Case Reports
Jordan M, Alessia C, Thibaud K, Christian T, et al.
Clinical case reports · 2023 · Case Reports
Timour G, Fréderic V, Olivier S, Shango DN
BMC infectious diseases · 2026 · Journal Article
Coulibaly H, Kpoda DS, Kafando H, Traoré O, et al.
Respiratory medicine and research · 2022 · Journal Article
Tenin K, Aurélien S, Daniela M, Denis C, et al.
International journal of geriatric psychiatry · 2024 · Journal Article
Monvoisin-Joly T, Furcieri E, Chabran E, Mondino M, et al.
Stem cells translational medicine · 2022 · Journal Article
Sophie S, Yves B, Frédéric B
Journal of the Pediatric Infectious Diseases Society · 2026 · Journal Article
Lenglart L, Levy C, Cahn-Sellem F, Zouari M, et al.
Journal of cosmetic dermatology · 2024 · Journal Article
Wang Y, Niu Y, Ye C, He X, et al.
Journal of medical virology · 2025 · Journal Article
Hota M, Wondeu ALD, Abakar MF, Dezoumbe K, et al.
BMJ case reports · 2026 · Journal Article
F A, George OK, Alex AG, Sahitya MS
The Journal of infection · 2024 · Journal Article
Clément L, Hélène D, Maud M, Chrystelle D, et al.